Form D · Other Investment Fund
Morpho Labs, a series of GCR JK LLC
New York, NY · CIK 0001922364
Offering snapshot reported Apr 15, 2022 · SEC filing
- Reported sold
- $89.3K Offering amount: $89.3K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $4.2K Reported outside-investor minimum
- First sale
- Apr 4, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 15, 2022 | Initial | $89,250 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-442017
Source: Form D, filed Apr 15, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gcr Jk Llc Gcr Jk Llc | Director |
| Jin Kang | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
5 Union Square West #1075
New York, NY, 10003
New York, NY, 10003